[Results of the use of chlormadinone and farlutal depot in hormonal therapy of uterine cancer].
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002715:Chlormadinone Acetate / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008525:Medroxyprogesterone / Q000008:administration & dosage / Q000031:analogs & derivatives*; D017258:Medroxyprogesterone Acetate; D013997:Time Factors; D014594:Uterine Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D002715:Chlormadinone Acetate; D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone
Wyniki stosowania chlormadinonu i farlutalu depot w hormonoterapii raka trzonu macicy.